Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr Infect Dis J. 2002; 21(9): 810-5.Harboe ZB, Valentiner-Branth P, Benfield TL, et al. Effectiveness of hep- tavalent pneumococcal conjugate vac...
1 Although a variety of viral and bacterial vaccines are now available to either reduce the severity of disease progression or prevent infection, approximately 1 in 6 pediatric organ recipients develop a vaccine-preventable infection (VPI) in the first 5 years after transplantation.2 This is ...
The scientific primary objective of DRIVE project is to calculate vaccine effectiveness (VE) for any influenza vaccine and brand-specific VE, against any influenza, by type and subtype/lineage. To this end, age- and setting-stratified pooled IVE estimates were calculated from test-negative design...
(Hib); by age 4 months: 2 Hep B, 2 DTP, 2 poliovirus, 2 Hib; by age 6 months: 2 Hep B, 3 DTP, 2 poliovirus, 3 Hib; by age 12 months: 2 Hep B, 3 DTP, 2 poliovirus, 3 Hib; by age 24 months: 3 Hep B, 4 DTP, 3 poliovirus, 3 Hib, 1 measles- containing vaccine. ...
Respiratory Syncytial Virus Inhibits Ciliagenesis in Differentiated Normal Human Bronchial Epithelial Cells: Effectiveness of N-Acetylcysteine Manuel Mata1,2*, Irene Sarrion1, Miguel Armengot3,4, Carmen Carda3, Isidoro Martinez2,5, Jose A. Melero2,6, Julio Cortijo1,2,3 1 R...
Tormans G, Van Damme P, Van Doorslaer E. Cost-effectiveness analysis of hep- atitis A prevention in travellers. Vaccine 1992;10(Suppl. 1):S88-92.Tormans G, Van Damme P, Van Doorslaer E. Cost- effectiveness analysis of hepatitis A prevention in travellers. Vaccine 1992 ; 10 (suppl. 1...
Second: To assess the effectiveness of HepB Vaccine in providing adequate immune protection. Methods: It is a retrospective study from 1st January 2009 to 31st December 2013 which includes newborns from hepatitis B carrier mother delivered at Centro Hospitalar Conde de Sao Januario (CHCSJ) ...
Methods. We used a dynamic model of hepatitis A infection to evaluate the impact of a two-dose vaccination program, administered at ages 12 and 18 months. The model incorporated the changing epidemiology of hepatitis A in Chile and the development of vaccine-induced...
We estimated the cost-effectiveness of this 3-antigen vaccine (PreHevbrio™) relative to the single-antigen vaccine, Engerix-BTM, to prevent hepatitis B virus (HBV) infection among US adults. Methods A cost-effectiveness model was developed using a combined decision-tree and Markov structure ...
State of the art of vaccine research and development. Report number WHO/IVB/05.XX.2011. Google Scholar World Health Organization, 2016 World Health Organization (2016). Table: Threshold values for intervention cost-effectiveness by Region. Retrieved 2nd December 2016 from http://www.who.int/...